Cath Lab Recap: CPR Devices Reclassified; Milestone for Amplatzer Interventional cardiology news to note
The Amplatzer patent foramen ovale (PFO) occluder snagged mostly positive votes from an FDA advisory committee on Tuesday. Members apparently considered the weak evidence for the device’s effectiveness — as demonstrated by three separate trials — less important than the perceived clinical need.